Source: ChildrensHealthDefense.org
The Centers for Disease Control and Prevention (CDC) is recommending more vaccines and vaccine doses across the board for children, pregnant women and adults, according to the agency’s 2024 immunization schedule.
The updated schedule triggered a flurry of news and reactions in recent days. However, the CDC released the updated schedule in September — months earlier than usual, to speed up insurance payments for newly recommended vaccines, the American Academy of Pediatrics reported.
The 2024 schedules include newly authorized recommendations for preventing COVID-19, respiratory syncytial virus (RSV), flu and pneumococcal disease.
“This amounts to nothing more than a very dangerous medical experiment foisted on America’s infants and children,” said Brian Hooker, Ph.D., senior director of science and research at Children’s Health Defense (CHD) and co-author of “Vax-Unvax: Let the Science Speak.”
Hooker told The Defender the CDC has never tested the efficacy or the safety of the entire childhood vaccination schedule.
Integrative physician Dr. Mary Kelly Sutton told The Defender, “The CDC continues to function as a powerful promoter of vaccines, not as a protector of public health.”
According to Sutton, who lost her license in three states for writing eight vaccine exemptions in California before the pandemic, there is little evidence of vaccines’ effectiveness and a lack of officially accepted research on their adverse effects. She said:
“The CDC could give wise guidance on vaccines but has so far accepted ACIP [Advisory Committee on Immunization Practices] approvals without studies. Universally, vaccines lack true placebo controls, and recently, lack human trials of any kind.
“The sad truth is pharma money rules the CDC, and the American people (and the world) are deceived and placed at risk.”
Commenting on the expanded vaccine schedule, Dr. Michelle Perro, a pediatrician and co-author of “What’s Making our Children Sick?” told The Defender, “It’s an outrage. It’s not necessary, and they’re hurting our children.”
#DYK that in the U.S. many physicians and their staff are not trained or experienced with evaluating patients for increased risk of #vaccine side effects beyond general contraindications recognized by the CDC? Read more: https://t.co/Lc6IIyLabn pic.twitter.com/aGoFMdX4eB
— Physicians for Informed Consent (@picphysicians) January 24, 2024
Perro criticized the financial incentives offered to doctors to vaccinate as many people as possible, and the reprisals against doctors for writing exemptions.
Pediatricians are bribed as well and this has been going on in their offices all throughout the U.S., but nobody seemed to care about that…why?
Pediatric offices will kick kids/families out of their practice for not following the bloated CDC childhood vaccine schedule! https://t.co/Ihwvt4S3Oz
— Gigi (@MommaGigiRN) January 20, 2024
Childhood (0-18) vaccine schedule
After carefully reviewing the new CDC schedules, CHD’s science team determined the likely minimum number for children ages 0-18 to be 76 doses of 18 different vaccines.
The number of doses could reach as high as 80, depending on the vaccine formulation being used and other factors.
By comparison, the CDC in 1983 recommended 11 doses of 7 vaccines by age 16, including the MMR (measles, mumps, rubella), DTP (diptheria, tetanus, pertussis), and polio vaccines.
New immunizations on the childhood schedule include:
- RSV: Nirsevimab (RSV-mAb, brand name Beyfortus) the monoclonal antibody treatment for children 0 through 8 months (if the mother did not receive the RSVpreF vaccine during pregnancy — see more information in the pregnancy section below), and certain high-risk children through 19 months. Additional guidance was added for locations with RSV seasonality that differs from that of the continental U.S.
- Pneumococcal: a 20-valent pneumococcal conjugate vaccine (PCV20), targeting 20 strains of Streptococcus pneumoniae, in four doses: at 2 months, 4 months, 6 months, and 12-15 months. PCV20 replaces PCV13, the 13-valent pneumococcal conjugate vaccine.
- COVID-19:
- For the Moderna mRNA shots:
- For children 6 months-4 years old: Those who have not been previously vaccinated are recommended to receive two doses of the “updated” 2023-24 Moderna vaccine. Those who have received one dose of any Moderna vaccine (including the updated version) or two doses of the older version are recommended to receive one dose of the updated vaccine.
- For children 5 years and older: Those who have received zero, one or two doses of the older vaccine are recommended to get one dose of the updated Moderna vaccine for their age group. If they have been previously vaccinated with at least one dose of the updated vaccine, no further shots are recommended.
- Note the timing for additional doses noted in the guidance.
- Note the different recommendations on Table 2A for people who are moderately or severely immunocompromised.
- For the Pfizer/BioNTech shots:
- For children 6 months-4 years old: Those who have not been vaccinated are recommended to take the three-shot series of the updated Pfizer/BioNTech vaccine. Those who have received one dose of any version (old or new) of the vaccine are recommended to get two more shots to complete the series. Those who have received two doses of any version (old or new) are recommended to receive one more shot to complete the series. Those who have received three or more shots of the older vaccine are recommended to get one shot of the new version. For those who have received three or more shots, including at least one dose of the new formulation, no further shots are recommended.
- For children 5 years and older: For those who are unvaccinated or have received any number of doses of the older Pfizer/BioNTech vaccine, they are recommended to get a single shot of the updated vaccine for their age group. For those who have previously received any number of doses including at least one of the new formulations, no further shots are required.
- Note the timing for additional doses noted in the guidance.
- Note the different recommendations on Table 2B for people who are moderately or severely immunocompromised.
- For the Moderna mRNA shots:
- Mpox (formerly monkeypox): Adults 18 and older who are at risk of mpox (gay, bisexual, transgender and nonbinary people with certain risk or exposure profiles) are recommended to receive the Jynneos vaccine. According to that guidance, the mpox vaccine appearing under the age-18 column on the childhood vaccine schedule is not expected to be administered to most children. Note that mpox clinical trials are currently underway for 12- to 17-year-olds.
Other changes to the childhood schedule include:
- DTaP (diphtheria, tetanus, pertussis for 0-6 year-olds): The note on this vaccine was revised to clarify primary and booster doses.
- Tdap (tetanus, diphtheria, and pertussis for 7-year-olds and older): The note was revised to clarify that the dose recommended for 11- to 12-year-olds is the adolescent booster dose.
- HPV (human papillomavirus): The routine vaccination section includes clarification about doses not recommended for those who have already completed the HPV series.
- Influenza: updated with recommended formulations for the 2023-24 flu season. Special notes about those with egg allergies have been removed; any person with a history of egg allergy can be vaccinated with these vaccines, according to the guidance.
- MMR: The note was updated to specify use for routine, catch-up and “special situation” vaccinations.
- MenB (meningococcal): Information about the newly licensed meningococcal A, B, C, W, Y vaccine has been added. A “shared clinical decision-making” document for individuals ages 16-23 was added.
- Pneumococcal: Sections have been updated for routine, catch-up and “special situation” vaccinations, with new recommendations for the use of the 15-valent pneumococcal conjugate vaccine (PCV15) and PPSV23, in addition to the information about PCV20 noted above.
- Poliovirus: New information has been added about catch-up vaccinations and increased risk exposure for 18-year-olds.
The CDC removed several vaccines from the schedule “because they no longer are distributed or recommended for use in the U.S.” These include bivalent mRNA COVID-19 vaccines, the diphtheria and tetanus toxoid vaccine (DT) and Menactra, a meningococcal vaccine.
The CDC published revised “vaccine catch-up guidance” for children who have fallen behind the recommended schedule. This includes guidance for the pneumococcal conjugate vaccine, Haemophilus influenzae type b vaccines (with guidance for different products), vaccines containing diphtheria, tetanus and pertussis (with specific guidance for formulations for different age groups) and the inactivated polio vaccine (IPV).
Additional catch-up guidance can be found in Table 2 of the childhood schedule….